These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 84706)

  • 1. Superiority of adriamycin-containing combination chemotherapy in the treatment of diffuse lymphoma: a Southwest Oncology Group study.
    Jones SE; Grozea PN; Metz EN; Haut A; Stephens RL; Morrison FS; Butler JJ; Byrne GE; Moon TE; Fisher R; Haskins CL; Coltman CA
    Cancer; 1979 Feb; 43(2):417-25. PubMed ID: 84706
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improved complete remission rates and survival for patients with large cell lymphoma treated with chemoimmunotherapy. A Southwest Oncology Group Study.
    Jones SE; Grozea PN; Metz EN; Haut A; Stephens RL; Morrison FS; Talley R; Butler JJ; Byrne GE; Hartsock R; Dixon D; Salmon SE
    Cancer; 1983 Mar; 51(6):1083-90. PubMed ID: 6185212
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemoimmunotherapy versus chemotherapy for remission induction in patients with non-Hodgkin's lymphoma: progress report of a Southwest Oncology Group study.
    Jones SE
    Recent Results Cancer Res; 1978; 65():164-9. PubMed ID: 85322
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improvement in complete response rate, duration of response and survival with adriamycin combination chemotherapy for non-Hodgkin lymphoma: a prognostic factor comparison of two regimens.
    Cabanillas F; Rodriguez V; Freireich EJ
    Med Pediatr Oncol; 1978; 4(4):321-31. PubMed ID: 364284
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sequential cyclophosphamide-prednisone and vincristine-bleomycin (CPOB). An effective, schedule-dependent treatment for advanced diffuse histiocytic lymphoma.
    Johnson GJ; Costello WG; Oken MM; Sponzo RW; Barnes JM; Ezdinli EZ; Bennett JM; Silverstein MN; Glick JH; Berard CW
    Cancer; 1983 Oct; 52(7):1133-41. PubMed ID: 6192894
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combination chemotherapy for mycosis fungoides: a Southwest Oncology Group study.
    Grozea PN; Jones SE; McKelvey EM; Coltman CA; Fisher R; Haskins CL
    Cancer Treat Rep; 1979 Apr; 63(4):647-53. PubMed ID: 87277
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prospectively randomized clinical trial of three intensive chemotherapy regimens for the treatment of advanced unfavorable histology non-Hodgkin's lymphoma.
    O'Connell MJ; Harrington DP; Earle JD; Johnson GJ; Glick JH; Carbone PP; Creech RH; Neiman RS; Mann RB; Silverstein MN
    J Clin Oncol; 1987 Sep; 5(9):1329-39. PubMed ID: 2442322
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Cyclophosphamide, adriamycin, vincristine, bleomycin and prednisolone (CHOP-Bleo) combination chemotherapy for advanced non-Hodgkin's lymphoma].
    Sampi K; Honda T; Hattori M; Takayama S
    Gan To Kagaku Ryoho; 1983 May; 10(5):1266-71. PubMed ID: 6191677
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemotherapy with cyclophosphamide, doxorubicin, vincristine, and prednisone alone or with levamisole or with levamisole plus BCG for malignant lymphoma: a Southwest Oncology Group Study.
    Jones SE; Grozea PN; Miller TP; Van Slyck EJ; Balcerzak SP; Costanzi JJ; Morrison FS; Eyre HJ; Fabian CJ; Dabich L
    J Clin Oncol; 1985 Oct; 3(10):1318-24. PubMed ID: 3900301
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The combined modality therapy of diffuse histology non-Hodgkin's lymphoma with cyclophosphamide, adriamycin, vincristine, prednisone (CHOP) and total body irradiation.
    Weick JK; Antunez A; Kraus TA; Fabian CJ; Dixon D
    Int J Radiat Oncol Biol Phys; 1983 Aug; 9(8):1205-7. PubMed ID: 6347997
    [TBL] [Abstract][Full Text] [Related]  

  • 11. European experience with ifosfamide in lymphomas.
    von Kalle AK; Schaadt M; Diehl V
    Semin Oncol; 1989 Feb; 16(1 Suppl 3):73-7. PubMed ID: 2468184
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Southwest Oncology Group clinical trials for intermediate- and high-grade non-Hodgkin's lymphomas.
    Miller TP; Dana BW; Weick JK; Jones SE; Coltman CA; Dahlberg S; Fisher RI
    Semin Hematol; 1988 Apr; 25(2 Suppl 2):17-22. PubMed ID: 2456619
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of a standard regimen (CHOP) with three intensive chemotherapy regimens for advanced non-Hodgkin's lymphoma.
    Fisher RI; Gaynor ER; Dahlberg S; Oken MM; Grogan TM; Mize EM; Glick JH; Coltman CA; Miller TP
    N Engl J Med; 1993 Apr; 328(14):1002-6. PubMed ID: 7680764
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Advances in chemotherapy for large cell lymphoma.
    Coleman M; Gerstein G; Topilow A; Lebowicz J; Berhardt B; Chiarieri D; Silver RT; Pasmantier MW
    Semin Hematol; 1987 Apr; 24(2 Suppl 1):8-20. PubMed ID: 2438781
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [A comparative study of CHOP therapy and COP-BLAM therapy for non-Hodgkin's lymphoma in elderly patients].
    Arai N; Hara A; Kaneko H; Umeda M; Shirai T
    Nihon Ronen Igakkai Zasshi; 1991 Sep; 28(5):672-7. PubMed ID: 1721658
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A 10-year update of CHOP-Bleo in the treatment of diffuse large-cell lymphoma.
    Lee R; Cabanillas F; Bodey GP; Freireich EJ
    J Clin Oncol; 1986 Oct; 4(10):1455-61. PubMed ID: 2428947
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term results of a multicenter randomized, comparative trial of modified CHOP versus THP-COP versus THP-COPE regimens in elderly patients with non-Hodgkin's lymphoma.
    Mori M; Kitamura K; Masuda M; Hotta T; Miyazaki T; Miura AB; Mizoguchi H; Shibata A; Saito H; Matsuda T; Masaoka T; Harada M; Niho Y; Takaku F
    Int J Hematol; 2005 Apr; 81(3):246-54. PubMed ID: 15814336
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Randomized study comparing doxorubicin, cyclophosphamide, vincristine, methotrexate with leucovorin rescue, and cytarabine (ACOMLA) with cyclophosphamide, doxorubicin, vincristine, prednisone, and bleomycin (CHOP-B) in the treatment of diffuse histiocytic lymphoma.
    Newcomer LN; Cadman EC; Nerenberg MI; Chen M; Bertino JR; Farber LR; Prosnitz LR
    Cancer Treat Rep; 1982 Jun; 66(6):1279-84. PubMed ID: 6177407
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combination chemotherapy of advanced non-Hodgkin lymphoma with bleomycin, adriamycin, cyclophosphamide, vincristine, and prednisone (BACOP).
    Skarin AT; Rosenthal DS; Moloney WC; Frei E
    Blood; 1977 May; 49(5):759-70. PubMed ID: 66957
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combination chemotherapy ("CHOP-Bleo") in advanced (non-Hodgkin) malignant lymphoma.
    Rodriguez V; Cabanillas F; Burgess MA; McKelvey EM; Valdivieso M; Bodey GP; Freireich EJ
    Blood; 1977 Mar; 49(3):325-33. PubMed ID: 65189
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.